Your browser doesn't support javascript.
loading
In vitro synergy of the combination of sulbactam-durlobactam and cefepime at clinically relevant concentrations against A. baumannii, P. aeruginosa and Enterobacterales.
Fouad, Aliaa; Nicolau, David P; Gill, Christian M.
Affiliation
  • Fouad A; Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA.
  • Nicolau DP; Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA.
  • Gill CM; Division of Infectious Diseases, Hartford Hospital, Hartford, CT, USA.
J Antimicrob Chemother ; 78(12): 2801-2809, 2023 12 01.
Article in En | MEDLINE | ID: mdl-37839896
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pseudomonas aeruginosa / Acinetobacter baumannii Limits: Humans Language: En Journal: J Antimicrob Chemother Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pseudomonas aeruginosa / Acinetobacter baumannii Limits: Humans Language: En Journal: J Antimicrob Chemother Year: 2023 Document type: Article Affiliation country: Country of publication: